Skip to main content

Second-line indication for ENHERTU

Written by patrippon on .

When

06/16/22    
3:30 pm - 6:30 pm
Download ICS Google Calendar iCalendar Office 365 Outlook Live

Join our broadcast to hear experts discuss more about the new second-line indication for ENHERTU®. Now approved to treat certain patients with HER2+ Metastatic Breast Cancer

 

Available Sessions

June 16, 2022 6:30PM ET

June 16, 2022  8:00PM ET

June 16, 2022  9:30PM ET

Registration: https://studio.mjhassoc.com/reach/2L-HER2Pos-mBC